Implications and Management of Pancreatic Fistulas Following Pancreaticoduodenectomy
Authors:
- Ismael DominguezIDIsmael Dominguez
- Cristina FerroneCFCristina Ferrone
- Sarah P. ThayerSTSarah P. Thayer
- Deborah McGrathDMDeborah McGrath
- Andrew L. WarshawAWAndrew L. Warshaw
- Carlos Fernández-Del CastilloCCCarlos Fernández-Del Castillo
Open Access
- 1 May 2008
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 143 (5) , 476-481
Abstract
Pancreatic fistulas are the hallmark of complications following pancreaticoduodenectomy, and numerous articles have addressed this problem, particularly their prevention. Because there was no attempt until recently to reach a consensus regarding what constitutes a pancreatic fistula,1 multiple definitions abound, and thus it has been difficult to analyze accurately the true clinical impact of this problem. To compound the lack of a consistent definition, there is a paucity of information regarding the best management strategies for this complication.1-3 While it is clear that a proportion of pancreatic fistulas have no, or very little, clinical impact, many still cause major morbidity and mortality.3-6 These clinically significant fistulas span a wide spectrum of severity, from a delay in hospital discharge and implementation of parenteral nutrition to an abscess or bleeding pseudoaneurysm. Included in this group are those patients who had an occult fistula. These are patients who initially appear to have no fistula based on drain output or amylase level but who present within weeks to months after surgery with intraabdominal collections, sepsis, and/or life-threatening hemorrhages. Some of these patients do not survive and, given the delay in presentation of their fistula, are sometimes not reported as having a pancreatic fistula and are not included in reported operative mortality statements. The objective of this study was to review our contemporary experience with pancreatic fistulas following pancreaticoduodenectomy, outline their management, and analyze their clinical impact.Keywords
This publication has 24 references indexed in Scilit:
- Conservative management of pancreatic fistula after pancreaticoduodenectomy with pancreaticogastrostomy1Journal of the American College of Surgeons, 2004
- Delayed hemorrhage after pancreaticoduodenectomy1Journal of the American College of Surgeons, 2004
- Octreotide Does Not Prevent Postoperative Pancreatic Fistula or Mortality following PancreaticoduodenectomyThe American Surgeon™, 2004
- The Potent Somatostatin Analogue Vapreotide Does Not Decrease Pancreas-Specific Complications After Elective Pancreatectomy: A Prospective, Multicenter, Double-Blinded, Randomized, Placebo-Controlled TrialJournal of the American College of Surgeons, 2003
- Ten-Year Experience With 733 Pancreatic ResectionsArchives of Surgery, 2001
- Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial.2000
- Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990sAnnals of Surgery, 1997
- A Prospective Randomized Trial of Pancreaticogastrostomy Versus Pancreaticojejunostomy After PancreaticoduodenectomyAnnals of Surgery, 1995
- Standards for Pancreatic Resection in the 1990sArchives of Surgery, 1995
- Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature.1991